This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
March, 2020
COVID-19
Special Study.
March, 2020
Introduction
• Due to the extensive impact of the SARS CoV 2 virus (COVID 19 pandemic, HMR developed an analysis of the weekly market evolution to understand a possible change in consumer behaviour at the pharmacy level in Ireland;
• In January and February the dispensary market and its main therapeutic classes have experienced weekly sales with very similar trends to the homologous weeks of 2019;
• This scenario started to change at the end of February ramping to a 4.7% growth in the first week of March, peaking in the second week of March with a growth of 28.1% and showing a growth of 15.4% in the third week, when compared to the exact same weeks of March 2019;
• In the 4th week of March the market has decreased by 1.9% vs last year, showing a possible supply normalisation of the
market when compared to the initial weeks of March.
• The main cause of this evolution is obviously related to the impact of CV 19;